Xufeng Dai

728 total citations
20 papers, 609 citations indexed

About

Xufeng Dai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, Xufeng Dai has authored 20 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Ophthalmology. Recurrent topics in Xufeng Dai's work include Retinal Development and Disorders (16 papers), Photoreceptor and optogenetics research (6 papers) and Retinal Diseases and Treatments (6 papers). Xufeng Dai is often cited by papers focused on Retinal Development and Disorders (16 papers), Photoreceptor and optogenetics research (6 papers) and Retinal Diseases and Treatments (6 papers). Xufeng Dai collaborates with scholars based in China, United States and Italy. Xufeng Dai's co-authors include Jijing Pang, William W. Hauswirth, Bo Chang, Sanford L. Boye, Astra Dinculescu, Yumiko Umino, Drew Everhart, Bo Lei, Juanjuan Han and Song Mao and has published in prestigious journals such as PLoS ONE, Human Molecular Genetics and Investigative Ophthalmology & Visual Science.

In The Last Decade

Xufeng Dai

19 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufeng Dai China 12 558 251 193 126 81 20 609
Drew Everhart United States 6 651 1.2× 248 1.0× 205 1.1× 180 1.4× 60 0.7× 8 696
Daniel M. Lipinski United States 16 800 1.4× 295 1.2× 253 1.3× 218 1.7× 138 1.7× 38 916
Selina A. Azam United Kingdom 8 634 1.1× 161 0.6× 282 1.5× 159 1.3× 78 1.0× 9 709
Lina Zelinger Israel 15 653 1.2× 246 1.0× 135 0.7× 183 1.5× 53 0.7× 19 733
Sue Pearce‐Kelling United States 8 473 0.8× 193 0.8× 165 0.9× 154 1.2× 110 1.4× 10 558
Élise Boulanger-Scemama France 11 431 0.8× 327 1.3× 324 1.7× 58 0.5× 169 2.1× 18 810
Thérèse Cronin France 13 678 1.2× 166 0.7× 286 1.5× 176 1.4× 53 0.7× 18 734
Sanne K. Verbakel Netherlands 7 638 1.1× 360 1.4× 156 0.8× 96 0.8× 131 1.6× 8 731
E. Fahl Germany 10 529 0.9× 354 1.4× 158 0.8× 45 0.4× 116 1.4× 15 726
Yunlu Xue United States 10 430 0.8× 201 0.8× 107 0.6× 94 0.7× 50 0.6× 15 532

Countries citing papers authored by Xufeng Dai

Since Specialization
Citations

This map shows the geographic impact of Xufeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufeng Dai more than expected).

Fields of papers citing papers by Xufeng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufeng Dai. The network helps show where Xufeng Dai may publish in the future.

Co-authorship network of co-authors of Xufeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xufeng Dai. A scholar is included among the top collaborators of Xufeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufeng Dai. Xufeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Xufeng, et al.. (2025). Piperine protects against cerebral ischemic injury by regulating the Caspase-1-mediated pyroptosis pathway. Frontiers in Pharmacology. 16. 1601873–1601873.
2.
Dai, Xufeng, Xiaoping Chen, Ting Jiang, et al.. (2020). Rodent retinal microcirculation and visual electrophysiology following simulated microgravity. Experimental Eye Research. 194. 108023–108023. 9 indexed citations
3.
Dai, Xufeng, et al.. (2018). Photoreceptor degeneration in a new Cacna1f mutant mouse model. Experimental Eye Research. 179. 106–114. 8 indexed citations
4.
Dai, Xufeng, Ying He, Hua Zhang, et al.. (2017). Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia. PLoS ONE. 12(11). e0188032–e0188032. 15 indexed citations
5.
Zhang, Hua, Xia Li, Xufeng Dai, et al.. (2017). The Degeneration and Apoptosis Patterns of Cone Photoreceptors in rd11 Mice. Journal of Ophthalmology. 2017. 1–13. 6 indexed citations
6.
Dai, Xufeng, Hua Zhang, Juanjuan Han, et al.. (2016). Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration. PLoS ONE. 11(5). e0156542–e0156542. 8 indexed citations
7.
Tao, Ye, Wen‐Tao Deng, Ping Zhu, et al.. (2015). Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia. Human Molecular Genetics. 24(13). 3699–707. 22 indexed citations
8.
Qi, Yan, Xufeng Dai, Hua Zhang, et al.. (2015). Trans-Corneal Subretinal Injection in Mice and Its Effect on the Function and Morphology of the Retina. PLoS ONE. 10(8). e0136523–e0136523. 43 indexed citations
9.
Zhang, Hua, Xufeng Dai, Yan Qi, et al.. (2015). Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives. Journal of Ophthalmology. 2015. 1–9. 31 indexed citations
10.
Dai, Xufeng, Juanjuan Han, Yan Qi, et al.. (2014). AAV-Mediated Lysophosphatidylcholine Acyltransferase 1 (Lpcat1) Gene Replacement Therapy Rescues Retinal Degeneration inrd11Mice. Investigative Ophthalmology & Visual Science. 55(3). 1724–1724. 21 indexed citations
11.
Pang, Jijing, Wen‐Tao Deng, Xufeng Dai, et al.. (2014). Correction: AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia. PLoS ONE. 9(1). 3 indexed citations
12.
Han, Juanjuan, Astra Dinculescu, Xufeng Dai, et al.. (2013). Review: the history and role of naturally occurring mouse models with Pde6b mutations.. PubMed. 19. 2579–89. 51 indexed citations
13.
Pang, Jijing, Wen‐Tao Deng, Xufeng Dai, et al.. (2012). AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia. PLoS ONE. 7(4). e35250–e35250. 97 indexed citations
14.
Pang, Jijing, Lingjie Lei, Xufeng Dai, et al.. (2012). AAV-Mediated Gene Therapy in Mouse Models of Recessive Retinal Degeneration. Current Molecular Medicine. 12(3). 316–330. 15 indexed citations
15.
Dai, Xufeng & Jijing Pang. (2012). [Progress on study of achromatopsia and targeted gene therapy].. PubMed. 48(8). 755–8. 1 indexed citations
16.
Pang, Jijing, Xufeng Dai, Sanford L. Boye, et al.. (2010). Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis Pigmentosa. Molecular Therapy. 19(2). 234–242. 126 indexed citations
17.
Kong, Fansheng, Wensheng Li, Xia Li, et al.. (2010). Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse. Experimental Eye Research. 90(5). 546–554. 45 indexed citations
18.
Pang, Jijing, Sanford L. Boye, Bo Lei, et al.. (2010). Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency. Gene Therapy. 17(7). 815–826. 63 indexed citations
19.
Li, Wensheng, Fansheng Kong, Xia Li, et al.. (2009). Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.. PubMed. 15. 267–75. 43 indexed citations
20.
Zheng, Jie, et al.. (2005). [Relationship between the polymorphism of carboxylic esterases and genetic susceptibility to organophosphates pesticides exposure].. PubMed. 23(2). 83–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Drew Everhart Breakdown of academic impact, for papers by Daniel M. Lipinski Breakdown of academic impact, for papers by Selina A. Azam Breakdown of academic impact, for papers by Lina Zelinger Breakdown of academic impact, for papers by Sue Pearce‐Kelling Breakdown of academic impact, for papers by Élise Boulanger-Scemama Breakdown of academic impact, for papers by Thérèse Cronin Breakdown of academic impact, for papers by Sanne K. Verbakel Breakdown of academic impact, for papers by E. Fahl Breakdown of academic impact, for papers by Yunlu Xue
Rankless by CCL
2026